https://elifesciences.org/reviewed-preprints/101401
Targeted anticancer pre-vinylsulfone covalent inhibitors of carbonic anhydrase IX
covalent inhibitorscarbonic anhydrasetargetedanticancerpre
https://www.cas.org/pt-br/resources/cas-insights/rise-covalent-inhibitors-strategic-therapeutic-design
Covalent inhibitors in strategic therapeutic design | CAS
Covalent inhibitor-drugs have generated billions of dollars in sales. Check out why they've become so popular among consumers and researchers.
covalent inhibitorsstrategictherapeuticdesigncas
https://elifesciences.org/articles/101401
Targeted anticancer pre-vinylsulfone covalent inhibitors of carbonic anhydrase IX | eLife
A series of compounds were synthesized and demonstrated to form a specific covalent bond with His64 of CAIX, an anticancer target, a strategy applicable to any...
carbonic anhydrase ixcovalent inhibitorstargetedanticancerpre
https://elifesciences.org/articles/82184
Targeting oncogenic KRasG13C with nucleotide-based covalent inhibitors | eLife
The important oncogene KRasG13C can be targeted by covalently binding nucleotide-analogues, resulting in a locked protein that can no longer induce oncogenic...
covalent inhibitorstargetingoncogenicnucleotidebased
https://www.cas.org/ja/resources/cas-insights/rise-covalent-inhibitors-strategic-therapeutic-design
Covalent inhibitors in strategic therapeutic design | CAS
Covalent inhibitor-drugs have generated billions of dollars in sales. Check out why they've become so popular among consumers and researchers.
covalent inhibitorsstrategictherapeuticdesigncas
https://www.cas.org/resources/cas-insights/rise-covalent-inhibitors-strategic-therapeutic-design
Covalent inhibitors in strategic therapeutic design | CAS
Covalent inhibitor-drugs have generated billions of dollars in sales. Check out why they've become so popular among consumers and researchers.
covalent inhibitorsstrategictherapeuticdesigncas
https://elifesciences.org/reviewed-preprints/101401v1/reviews
Targeted anticancer pre-vinylsulfone covalent inhibitors of carbonic anhydrase IX
covalent inhibitorscarbonic anhydrasetargetedanticancerpre
https://www.ncbi.nlm.nih.gov/Structure/pdb/9FKZ
9FKZ: Discovery of a Series of Covalent, Cell Active Bfl-1 Inhibitors
Bcl-2-related protein A1
discovery ofa series
https://www.rcsb.org/structure/1MHW
RCSB PDB - 1MHW: Design of non-covalent inhibitors of human cathepsin L. From the 96-residue...
Design of non-covalent inhibitors of human cathepsin L. From the 96-residue proregion to optimized tripeptides
https://pmc.ncbi.nlm.nih.gov/articles/PMC10205138/
Discovery of quinazolin-4-one-based non-covalent inhibitors targeting the severe acute respiratory...
The COVID-19 pandemic caused by SARS-CoV-2 continues to pose a great threat to public health while various vaccines are available worldwide. Main protease...
https://pmc.ncbi.nlm.nih.gov/articles/PMC9827112/
Creating MHC-Restricted Neoantigens with Covalent Inhibitors That Can Be Targeted by Immune Therapy...
Cancer-specific neoantigens created in the form of a covalent drug conjugated to a fragment of an intracellular oncoprotein selectively mark drug-resistant...
https://www.cas.org/resources/webinar/webinar-bond-worth-forming-rise-targeted-covalent-inhibitors
Webinar: A Bond Worth Forming: The Rise of Targeted Covalent Inhibitors | CAS
Join our expert panel to explore targeted covalent inhibitors, their role in addressing challenging targets, and insights into the inhibitor landscape.
targeted covalent inhibitorsthe rise
https://www.ncbi.nlm.nih.gov/Structure/pdb/8DIC
8DIC: Virtual screening for novel SARS-CoV-2 main protease non-covalent and covalent inhibitors
3C-like proteinase nsp55-bromo-3-[(3-bromo-4-chlorophenyl)methoxy]pyridine-2-carbaldehyde
sars cov 2 main protease
https://www.rcsb.org/structure/1QHR
RCSB PDB - 1QHR: NOVEL COVALENT ACTIVE SITE THROMBIN INHIBITORS
NOVEL COVALENT ACTIVE SITE THROMBIN INHIBITORS
rcsb pdbactive sitenovelcovalentthrombin
https://www.news-medical.net/webinar/Kinetic-Characterization-of-Covalent-Inhibitors-on-the-PHERAstar
Kinetic Characterization of Covalent Inhibitors
Kinetic Characterization of Covalent Inhibitors on the PHERAstar
kineticcharacterizationcovalentinhibitors